Myasthenia Gravis News is providing virtual coverage of the 2023 Annual Meeting for the American Academy of Neurology taking place April 22-27 in Boston. Stay tuned to this page for all the latest news.
Repeated treatment with under-the-skin efgartigimod had a consistent effect in easing symptoms of generalized myasthenia gravis (gMG), with no new safety issues identified. That’s according to interim data from the Phase 3 extension study ADAPT-SC+ (NCT04818671), which is…